Interview: AZ’s immunotherapy gamble starts to pay off – pharmaphorum
pharmaphorum |
Interview: AZ's immunotherapy gamble starts to pay off
pharmaphorum Robert Iannone, AstraZeneca's head of immune-oncology drug development talks to pharmaphorum about the unpredictable immunotherapy market, the PACIFIC trial success, and further changes ahead. Fortunes are very changeable in the … |
